COMMUNIQUÉS West-GlobeNewswire

Trinitas-St. Joseph’s Behavioral Health Network Offers Innovative Alternative Treatment for Depression
04/04/2018
Transcranial Magnetic Stimulation (TMS) helps adult patients with depression who have not benefited from initial antidepressant medication therapies PATERSON, N.J., April 04, 2018 (GLOBE NEWSWIRE) -- The Trinitas-St. [...]
CrownBio to Showcase Scientific Expertise in Preclinical Drug Development at the American Association for Cancer Research (AACR) Conference
04/04/2018
SAN DIEGO, April 04, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience , a wholly-owned subsidiary of Crown Bioscience International (TWSE:6554) and a global drug discovery and development services company providing [...]
Rezolute Announces Appointment of Hoyoung Huh, M.D., Ph.D. as Vice Chairman of its Board of Directors
04/04/2018
LOUISVILLE, Colo., April 04, 2018 (GLOBE NEWSWIRE) -- Rezolute , Inc. (“Rezolute” or the “Company”) (OTCQB:RZLT), a clinical stage biopharmaceutical company specializing in the development of innovative drug therapies [...]
Cellectar Biosciences Appoints Brian M. Posner as Chief Financial Officer
04/04/2018
MADISON, Wis., April 04, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB ), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted [...]
Keryx Biopharmaceuticals Announces Publication of Data from the Phase 3 Trial of Auryxia® (ferric citrate) for Iron Deficiency Anemia in Patients with Chronic Kidney Disease, Not on Dialysis, in the American Journal of Hematology
04/04/2018
BOSTON, April 04, 2018 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ), a biopharmaceutical company focused on bringing innovative medicines to people with kidney disease, today announced the [...]
Abiomed Announces European Approval (CE Marking) for Impella 5.5™ and First Patient Treated at University Heart Center Hamburg
04/04/2018
DANVERS, Mass., April 04, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ: ABMD ), a leading provider of breakthrough heart recovery and support technologies, announced today that the Impella 5.5™ heart pump received CE [...]
Mustang Bio to Present at Biotech Innovations Conference
04/04/2018
NEW YORK, April 04, 2018 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO ), a Fortress Biotech (NASDAQ: FBIO ) Company focused on the development of novel immunotherapies based on proprietary chimeric [...]
Tauriga Sciences Inc. Increases its Stake in Crypto Currency Groestlcoin (Code: GRS); Company Now Holds 39,862 GRS Units
04/04/2018
NEW YORK, NY, April 04, 2018 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTC PINK: TAUG ) ("Tauriga" or the "Company"), engaged in building its business through the development, distribution, and licensing of [...]
VHA Home HealthCare Honours Outstanding Family Caregivers on National Carers Day
04/04/2018
TORONTO, April 04, 2018 (GLOBE NEWSWIRE) -- VHA Home HealthCare (VHA) honoured three caregiving heroes—Zulfikar Alladina of Toronto, Taylor Allen of Welland, and Madolina Sasa of Scarborough—who won this year’s Heart of [...]
Shire plc : Director Declaration
04/04/2018
Director Declaration April 4, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company") announces that Susan Kilsby, Chairman of the Company, was appointed as a Non-Executive Director of Diageo plc on April 4, 2018. [...]
Cannabis Wheaton Announces Definitive Acquisition Agreement With Dosecann
04/04/2018
VANCOUVER, British Columbia, April 04, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (TSX-V: CBW ) (" Cannabis Wheaton " or the " Company ") announces that it has entered into a definitive acquisition agreement [...]
Tonix Pharmaceuticals to Present FDA Breakthrough Therapy-Designated PTSD Program at the MicroCap Conference in New York
04/04/2018
First 50 Percent of Participants Enrolled in Phase 3 HONOR Study of Tonmya® (Cyclobenzaprine HCl Sublingual Tablets) for the Treatment of Military-Related PTSD Interim Results of HONOR Study Expected in Third Quarter [...]
Loxo Oncology Announces Acceptance of LOXO-292 Oral Presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting
04/04/2018
STAMFORD, Conn., April 04, 2018 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq: LOXO ), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers [...]
Helius Medical Technologies, Inc. Announces Proposed Public Offering of Class A Common Stock and Warrants
04/04/2018
NEWTOWN, Pa., April 04, 2018 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (TSX: HSM ) (OTCQB:HSDT) (“ Helius ” or the “ Company ”) announced today that it intends to offer and sell, subject to market conditions [...]
Global Autism Project Partners With Leading Technology and Behavioral Health Experts Rethink
04/04/2018
NEW YORK, April 04, 2018 (GLOBE NEWSWIRE) -- Global Autism Project is excited to announce their new partnership with leading technology and behavioral health experts, Rethink Behavioral Health. In this collaboration, [...]
Curetis' Unyvero BCU Blood Culture Application Receives Approval from Singapore Health Sciences Authority
04/04/2018
Curetis ' Unyvero BCU Blood Culture Application Receives Approval from Singapore Health Sciences Authority Second market authorization for Unyvero Cartridges this year in Singapore Amsterdam, the Netherlands, and [...]
Amarin Updates First Quarter Revenue Guidance, Reiterates Full Year Guidance and Updates on REDUCE-IT Cardiovascular Outcomes Study Progress and Vascepa® Promotion Initiatives
04/04/2018
Over 97% of Final Patient Visits in REDUCE-IT Completed or Scheduled for Near-Term Completion BEDMINSTER, N.J. and DUBLIN, Ireland, April 04, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN ), a [...]
Amarin’s REDUCE-IT Cardiovascular Outcomes Study Reaches 100% Mark for Estimated Onset of Target Primary Major Adverse Cardiovascular Events
04/04/2018
On Track to Report REDUCE-IT Results Before the End of Q3 2018 BEDMINSTER, N.J., and DUBLIN, Ireland, April 04, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN ), a biopharmaceutical company focused on the [...]
Helsinn Group and Glenmark Pharmaceuticals enter into an exclusive licensing agreement for launch of AKYNZEO® in India and Nepal
04/04/2018
Helsinn Group and Glenmark Pharmaceuticals enter into an exclusive licensing agreement for launch of AKYNZEO® in India and Nepal AKYNZEO®, containing netupitant 300mg and palonosetron 0.5mg, is used for prevention of [...]

Pages